Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Cash & Current Investments (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Cash & Current Investments data on record, last reported at $1.9 billion in Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 70.69% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $1.9 billion, up 70.69%, while the annual FY2025 figure was $1.9 billion, 70.69% up from the prior year.
  • Cash & Current Investments reached $1.9 billion in Q4 2025 per PTCT's latest filing, up from $1.7 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $2.0 billion in Q1 2025 and bottomed at $286.3 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $947.3 million, with a median of $880.8 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: crashed 66.77% in 2022, then surged 243.73% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $773.4 million in 2021, then crashed by 46.89% to $410.7 million in 2022, then surged by 113.47% to $876.7 million in 2023, then grew by 29.99% to $1.1 billion in 2024, then skyrocketed by 70.69% to $1.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $1.9 billion in Q4 2025, $1.7 billion in Q3 2025, and $2.0 billion in Q2 2025.